glp-1 and liver disease Current Status of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatotic Disease: A Clinical Perspective Therapeutic Mechanisms and Clinical Effects
Description
doi: 10.1038/s43016-024-01095-7, 124 RheaE

doi:10.1016/j.phrs.2015.02.003 112

Allergen Information: Contains Milk

Prices start as low as $149 a month
This has prompted research into whether GLP-1 therapy influences skeletal health, particularly given the substantial weight loss these medications can produce
The severity and frequency of side effects vary
